BRYHALI (HALOBETASOL PROPIONATE) — FDA Approval NDA209355 (BAUSCH)
BRYHALI (HALOBETASOL PROPIONATE) — FDA Approval NDA209355 (BAUSCH) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: BRYHALI; Active ingredients: HALOBETASOL PROPIONATE; Application number: NDA209355.
| Brand name | BRYHALI |
|---|---|
| Active ingredients | HALOBETASOL PROPIONATE |
| Application number | NDA209355 |
| Sponsor | BAUSCH |
| Dosage form | LOTION |
| Route | TOPICAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20181106 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →